debate: optimal approach for stage iii nsclc - trimodality therapy
Published 7 years ago • 218 plays • Length 14:38Download video MP4
Download video MP3
Similar videos
-
14:46
debate: optimal approach for stage i nsclc - surgery
-
14:43
debate: strategies for locally advanced nsclc - trimodality approach
-
10:45
debate: what is the optimal chemotherapy for stage iii nsclc? - cisplatin/etoposide is the standard
-
11:05
debate: what is the optimal chemotherapy for stage iii nsclc? - taxane/carboplatin is the standard
-
10:26
debate: strategies for locally advanced nsclc - bimodality approach
-
12:41
debate: surgery for stage iiia patients with lung cancer? - yes
-
7:24
debate: surgery for stage iiia patients with lung cancer? - no
-
11:27
case based panel discussion - stage 3 nsclc, frail patient competing risks, best treatment approach?
-
11:56
debate: adjuvant therapy for resected node negative stage i nsclc? - never
-
14:39
debate: adjuvant therapy for resected node negative stage i nsclc? - sometimes
-
25:26
locally advanced nsclc: combination therapy with targeted and immunotherapy agents
-
4:43
treating for stage iii nsclc after progression on durvalumab
-
6:20
asco lung cancer highlights, part 4: exploring the role of trimodality therapy for stage iii nsclc
-
15:54
gracecast-075_lung-cancer_ccilc - optimal treatment for stage iiia n2 node-positive nsclc
-
21:16
locally advanced nsclc: choice and sequencing of systemic agents in combined modality therapy
-
10:45
debate: adjuvant egfr-directed therapy for patients with early stage nsclc? - no
-
10:08
case based panel discussion stage 3 nsclc - does timing of treatment make a difference in response.
-
6:00
immunotherapy approaches in unresectable stage iii nsclc: what’s on the horizon?
-
6:41
the role of surgery in nsclc following pacific trial